Navigation
Trademark Information
Application ID
Status
Date of Application
24 May 2012
Classes
5
Proprietor
"Jamals Sonu Terrace", #42/1, Loganathan Nagar, 1st Street, 100 Feet Road,Choolaimedu, Chennai 600094
Agent
Nair & Nair Associates[11425]
Lalith B. Nair
Nair And Nair Associates
Office No. 126, Seawood Corner,
Plot No. 19 A, Sector 25,
Seawoods East, Nerul,
Navi Mumbai 400 706.
Type
Device
State
Tamil Nadu
Country
Filing Mode
Branch Office
IP Office
CHENNAI
Used Since
Valid / Upto
24 May 2032
Description
[Class : 5] Medicinal And Pharmaceuticals Preparations
Image (DEVICE)
Documents
| Examination Report |
Uploaded Documents
| 1 | TM-1 | 24 May 2012 |
| 2 | Reply to Exam Report (MIS-R) | 01 Sep 2014 |
| 3 | Journal Copy | 01 Sep 2016 |
| 4 | Certificate | 23 Sep 2016 |
| 5 | TM-P(ALTER ADDRESS OF REGISTERED PROP/USER) | 20 May 2022 |
| 5 | TM-R(RENEWAL OF TRADE MARK) | 20 May 2022 |
| 6 | TM-P(ALTER ADDRESS OF REGISTERED PROP/USER) | 20 May 2022 |
| 6 | TM-R(RENEWAL OF TRADE MARK) | 20 May 2022 |
| 7 | Returned Notices / Correspondences | 23 Aug 2024 |
| 8 | Returned Notices / Correspondences | 23 Aug 2024 |
Correspondence and Notices
| 1 | O3 NOTICE | 13045042 | 5530114 | 18 Feb 2022 |
| 2 | RENEWAL INTIMATION LETTER | 13532925 | 24 May 2022 |
Frequently Asked Questions
What is the application date as per IP India website?
As per IP India data the trademark was applied on 24 May 2012.
Who has filed the trademark application with the TMO?
REGENIX DRUGS applied for Lmfolate.
What is the listed class of the Lmfolate with IP India?
Listed class of trademark Lmfolate is 5.
As per IP india what is the stage of trademark application?
Lmfolate is on the Registered stage of the trademark process.
What is the Serial number provided by the trademark data?
Serial Number provided to trademark application is 2336831
Who filed the trademark on behalf of the proprietor?
Trademark application was filed by the following attorney agent:
Nair & Nair Associates
How is the Lmfolate categorized?
The trademark is categorized as DEVICE.